AMAG Pharmaceuticals Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

AMAG Pharmaceuticals Inc (AMAG) is a pharmaceutical company focused on the development and commercialization of specialty pharmaceutical products in therapeutic areas like maternal, women’s health, anemia management and hematology. Its products portfolio include Makena an auto-injector device, Feraheme for intravenous, Intrarosa for vaginal inserts and Vylees an auto-injector device. The company is developing two product pipelines; Ciraparantag is in Phase 2b trial of healthy volunteers and AMAG-423 is in phase 2b/3a trial. The company offers its products through a direct sales force and a network of distributors. AMAG is headquartered in Waltham, Massachusetts, the US.

AMAG Pharmaceuticals Inc Key Recent Developments

Oct 02,2020: Covis Group to acquire AMAG Pharmaceuticals for $647m
Aug 06,2020: AMAG Pharmaceuticals announces second quarter 2020 financial results and provides corporate update
Jun 12,2020: AMAG Pharmaceuticals to lay off 35 workers at Waltham, Massachusetts site
Jun 11,2020: AMAG Pharmaceuticals announces leadership changes
May 12,2020: AMAG Pharmaceuticals to lay off 32 workers at Waltham, Massachusetts site

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.